Beren is a public benefit corporation built to make life-changing medicines in partnership with patients, caregivers, clinicians, and health systems.

Through its fully integrated discovery capabilities, Beren is advancing a growing pipeline of unique derivatized cyclodextrins that traffic accumulated cholesterol for cellular use or elimination, restoring cellular cholesterol homeostasis.